Sanofi shells out $11.6bn on Bioverativ by Selina McKee | Jan 22, 2018 | News | 0 Sanofi is fortifying its presence in the field of blood disorders through the purchase of Bioverativ in a deal valued at some $11.6 billion. Read More
Sanofi snaps up Protein Sciences for $650 million by Selina McKee | Jul 11, 2017 | News | 0 Sanofi is to buy private US vaccines biotech Protein Sciences in a deal valued at up to $750 million, in a move to bolster its vaccines portfolio. Read More